STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Glioblastoma multiforme (GBM) is an aggressive brain tumor with complex genetic underpinnings.
• The tumor suppressor p53 plays a critical role in cancer, but its precise regulatory networks in GBM are not fully elucidated.
• Quaking (QKI), an RNA-binding protein, has been identified as a potential tumor suppressor in GBM.

Purpose of the Study:

• To investigate the role of Quaking (QKI) in glioblastoma multiforme (GBM) tumor suppression.
• To elucidate the molecular pathway through which QKI exerts its tumor suppressive functions.
• To understand the interplay between p53, QKI, microRNA-20a (miR-20a), and the TGFβ signaling network in GBM.

Main Methods:

• In silico epistasis analysis using The Cancer Genome Atlas (TCGA) data for GBM.
• Gain- and loss-of-function studies in vitro and in vivo.
• Analysis of gene expression, protein interactions, and microRNA regulation.
• Validation of the p53-QKI-miR-20a-TGFβ pathway.

Main Results:

• p53 directly regulates the expression of the Quaking (QKI) gene.
• QKI protein stabilizes miR-20a, which in turn targets TGFβ receptor 2 (TGFβR2).
• This regulatory axis impacts the TGFβ signaling network, a key pathway in cancer.

Conclusions:

• The identified p53-QKI-miR-20a-TGFβ pathway represents a novel mechanism of tumor suppression in GBM.
• This pathway expands the known functions of p53 in cancer and highlights the role of microRNA regulation in tumor suppression.
• QKI acts as a novel tumor suppressor by modulating specific cancer-relevant microRNAs in GBM.